A smart implantable pump for advanced heart failure
Heart failure is a life-threatening condition in which the heart is unable to pump enough blood to meet the needs of the body. For patients with advanced heart failure and who are either too old or not suitable for a heart transplant, implantable left ventricular assist devices (LVADs) have emerged as a new treatment option. The EU-funded Calypso project will bring to market a game-changing LVAD developed by the French CORWAVE company. This new device relies on a unique and patented breakthrough technology, the wave membrane. Unlike current devices, which are continuous-flow rotary pumps, CorWave LVAD is a smart pump producing a physiologic and pulsatile blood flow, to restore a normal life to patients with minimal side effects.
Fields of science
Call for proposalSee other projects for this call